Search results for "Vaccination"
ACIP releases 2024 Adult Immunization Schedule featuring new vaccines
The latest recommendations from the Advisory Committee on Immunization Practices (ACIP) address vaccines against respiratory syncytial virus, mpox, COVID-19, and meningitis, among others.
https://immattersacp.org/weekly/archives/2024/01/16/1.htm
16 Jan 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2024
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024
Looking ahead at the past
ACP membership inspires through its principles, opportunities, and relevance.
https://immattersacp.org/archives/2024/01/looking-ahead-at-the-past.htm
1 Jan 2024
Recombinant flu vaccine appears to provide benefit in patients ages 50 to 64 years
An industry-funded study compared a high-dose recombinant influenza vaccine with one of two standard-dose egg-based vaccines over two flu seasons and found patients who received a high-dose vaccine were less likely to test positive for flu.
https://immattersacp.org/weekly/archives/2023/12/19/2.htm
19 Dec 2023
CDC publishes guidance on testing for flu, COVID-19
Patients presenting with acute respiratory illness should be tested for SARS-CoV-2 with nucleic acid detection or antigen detection assay, as well as flu if the results will change clinical management or infection control decisions, the CDC said.
https://immattersacp.org/weekly/archives/2023/12/19/1.htm
19 Dec 2023
ACP urges adults to get their influenza vaccine during National Influenza Vaccination Week
ACP is urging all adults to get vaccinated as influenza season, holiday gatherings, and winter weather are here, along with the continued presence of COVID-19 and respiratory syncytial virus.
https://immattersacp.org/weekly/archives/2023/12/05/5.htm
5 Dec 2023
Modeling study finds RSV vaccines cost-effective for older U.S. adults
Vaccination programs using the monovalent adjuvanted or bivalent vaccine against respiratory syncytial virus (RSV) were projected to be potentially cost-effective at a price per dose of up to $127 or up to $118, respectively, over a first RSV season.
https://immattersacp.org/weekly/archives/2023/12/05/4.htm
5 Dec 2023
MKSAP Quiz: Evaluation for multiple myeloma
A 64-year-old man is evaluated following a recent diagnosis of multiple myeloma. Chemotherapy is planned to begin in 14 days. Which prophylactic therapy is indicated today?
https://immattersacp.org/weekly/archives/2023/12/05/3.htm
5 Dec 2023
One-fifth of COVID-19 patients taking nirmatrelvir-ritonavir had viral rebound
A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
https://immattersacp.org/weekly/archives/2023/11/14/4.htm
14 Nov 2023